Concepedia

Author

Christophe Ferrand

InsermORCID

Also Known As

C Ferrand, C. Ferrand, CHRISTOPHE FERRAND, Christophe FERRAND, Christophe Ferrand, Ferrand Christophe, Ferrand, Christophe

190

Publications

4.3K

Citations

35

H-Index

100

Concepts

All Affiliations

InsermCentre Hospitalier Universitaire de BesançonUniversité de franche-comtéÉtablissement Français du SangUniversité Bourgogne Franche-Comté
CF

About

Christophe Ferrand is an author at Inserm specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

32

1.7K

2

Health Sciences

3

3

114

3

Engineering

1

1

10

4

Natural Sciences

1

1

48

5

Public Health

1

1

63

Christophe Ferrand

×

75

Publications

4K

Citations

35

H-Index

YearCitations

Evidence of premature immune aging in patients thymectomized during early childhood

Delphine Sauce, Martin Larsen, Solène Fastenackels,

Journal of Clinical Investigation

2009

270

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia

Marlène Pasquet, Christine Bellanné‐Chantelot, Suzanne Tavitian,

Blood

2012

206

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

Francine Garnache‐Ottou, Jean Feuillard, Christophe Ferrand,

British Journal of Haematology

2009

175

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation

Marina Deschamps, Maria Yannaraki, Christophe Ferrand,

Kidney International

2005

160

Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion

F. Kleinclauss, Sylvain Perruche, Emeline Masson,

Cell Death and Differentiation

2005

147

Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti–Epstein-Barr virus potential through both culture-dependent and selection process–dependent mechanisms

Delphine Sauce, Marie Bodinier, Marina Garín,

Blood

2002

120

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé,

Blood Advances

2019

120

Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes

Sylvain Audia, Alexandra Nicolas, Dominique Cathelin,

Clinical & Experimental Immunology

2007

117

New advances in DPYD genotype and risk of severe toxicity under capecitabine

Marie-Christine Étienne-Grimaldi, Jean-Christophe Boyer, Christophe Béroud,

PLoS ONE

2017

102

Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients

Thomas Crépin, Mathieu Legendre, Clémence Carron,

Nephrology Dialysis Transplantation

2018

99

Page 1